| Title: | FDA's role in the evaluation of Avandia's safety : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007. |
| Author: | United States. Congress. House. Committee on Oversight and Government Reform |
| Note: | U.S. G.P.O. :, 2008 |
| Link: | page images at HathiTrust |
| No stable link: | This is an uncurated book entry from our extended bookshelves, readable online now but without a stable link here. You should not bookmark this page, but you can request that we add this book to our curated collection, which has stable links. |
| Subject: | Diabetes -- Chemotherapy |
| Subject: | Drugs -- United States -- Testing |
| Subject: | Rosiglitazone -- Side effects |
| Subject: | United States. Food and Drug Administration |
| Other copies: | Look for editions of this book at your library, or elsewhere. |
Help with reading books -- Report a bad link -- Suggest a new listing
Home -- Search -- New Listings -- Authors -- Titles -- Subjects -- Serials
Books -- News -- Features -- Archives -- The Inside Story
Edited by John Mark Ockerbloom (onlinebooks@pobox.upenn.edu)
OBP copyrights and licenses.